Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

Poster Display session

196P - An international consensus on actions to improve lung cancer survival: A clinical review by the international cancer benchmarking partnership (ICBP)


03 Apr 2022


Poster Display session


Charlotte Lynch


Annals of Oncology (2022) 33 (suppl_2): S117-S121. 10.1016/annonc/annonc858


C. Lynch1, S. Harrison1, J. Butler2, D.R. Baldwin3, P. Dawkins4, J. van der Horst5, E. Jakobsen6, J. McAleese7, A. McWilliams8, K. Redmond9, A. Swaminath10, C. Finley11

Author affiliations

  • 1 Cancer Research UK, London/GB
  • 2 Royal Marsden NHS Foundation Trust, London/GB
  • 3 City Hospital Campus - Nottingham University Hospitals NHS Trust, Nottingham/GB
  • 4 Middlemore Hospital, Auckland/NZ
  • 5 Glasgow Royal Infirmary, Glasgow/GB
  • 6 Odense University Hospital, Odense/DK
  • 7 Belfast City Hospital, Belfast/GB
  • 8 Fiona Stanley Hospital, Perth/AU
  • 9 Mater Misericordiae University Hospital, Dublin/IE
  • 10 McMaster University, Hamilton/CA
  • 11 St Joesph's Healthcare Hamilton, Hamilton/CA

Abstract 196P


ICBP research demonstrates the greatest variation in lung cancer survival internationally is within early stage disease. There is a current lack of published international consensus on critical contributing components to variation in outcomes and the steps needed to optimise lung cancer services to improve the quality of options for and equitable access to treatment, and ultimately improve survival.


Semi-structured interviews were conducted with 9 key informants from ICBP countries. An international clinical network was established to share local clinical insights and examples of best practice. Network members suggested and rated recommendations to optimise the management of lung cancer (using a modified Delphi consensus model). Calls to action were developed as the most crucial recommendations, with Good Practice Points included to support their implementation.


Five Calls to Action and thirteen Good Practice Points were developed and achieved 100% consensus. Calls to Action include (1) Implement cost-effective, clinically efficacious and equitable lung cancer screening initiatives; (2) Ensure diagnosis of lung cancer within 30 days of referral; (3) Develop Thoracic Centres of Excellence; (4) Undertake an international audit of lung cancer care; and (5) Recognise improvements in lung cancer care and outcomes as a priority in cancer policy.


The recommendations presented are the voice of an expert international lung cancer clinical network, and signpost key considerations for policymakers in countries within the ICBP but also in other comparable countries. These define a roadmap to help align and focus efforts in improving outcomes and management of lung cancer patients globally.

Legal entity responsible for the study

The authors.


Has not received any funding.


All authors have declared no conflicts of interest.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.